RBC Capital Upgrades Cardiome Pharma (CRME) to Outperform
Tweet
Share
E-mailGet Alerts CRME Hot Sheet
Price: $2.33 --0%
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Join SI Premium – FREE
RBC Capital upgraded Cardiome Pharma (NASDAQ: CRME) from Sector Perform to Outperform. PT increased to $8.40.
For more ratings news on Cardiome Pharma click here and for the rating history of Cardiome Pharma click here.
Shares of Cardiome Pharma closed at $4.41 yesterday.
For more ratings news on Cardiome Pharma click here and for the rating history of Cardiome Pharma click here.
Shares of Cardiome Pharma closed at $4.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Covivio (COV:FP) to Buy
- Jefferies Upgrades Energean Oil & Gas (ENOG:LN) (EERGF) to Hold
- Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
